Over-expression of 14-3-3σ in budding colorectal cancer cells modulates cell migration in the presence of tenascin-C

Oncology Reports

Volumn 18, Issue 6, 2007, Pages 1451-1456

  Ide, Munenori ^a   Saito, Kana ^a   Tsutsumi, Soichi ^a   Tsuboi, Kaori ^a   Yamaguchi, Satoru ^a   Asao, Takayuki ^a   Kuwano, Hiroyuki ^a   Nakajima, Takashi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

14 3 3 ; Colorectal cancer; Migration; Tenascin C

Indexed keywords

EXONUCLEASE; SFN PROTEIN, HUMAN; TENASCIN; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CANCER STAGING; CELL COUNT; CELL DIVISION; CELL MOTION; COLORECTAL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TUMOR CELL LINE;

CELL COUNT; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; EXONUCLEASES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; TENASCIN; TUMOR MARKERS, BIOLOGICAL;

EID: 38449095554     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Mhawech P: 14-3-3 proteins - an update. Cell Res 15: 228-236, 2005.
2. Lopez-Girona A, Furnari B, Mondesert O and Russell P: Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature 397: 172-175, 1999.
3. Xing H, Zhang S, Weinheimer C, Kovacs A and Muslin AJ: 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades. EMBO J 19: 349-358, 2000. (Pubitemid 30072605)
4. Han DC, Rodriguez LG and Guan JL: Identification of a novel interaction between integrin beta1 and 14-3-3beta. Oncogene 20: 346-357, 2001. (Pubitemid 32142324)
5. Gohla A and Bokoch GM: 14-3-3 regulates actin dynamics by stabilizing phosphorylated cofilin. Curr Biol 12: 1704-1710, 2002. (Pubitemid 35161927)
6. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW and Vogelstein B: 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1: 3-11, 1997. (Pubitemid 127376388)
7. Chan TA, Hermeking H, Lengauer C, Kinzler KW and Vogelstein B: 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 401: 616-620, 1999.
8. Laronga C, Yang HY, Neal C and Lee MH: Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem 275: 23106-23112, 2000. (Pubitemid 30646202)
9. Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H, Marks JR, Lambers AR, Futreal PA, Stampfer MR and Sukumar S: High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 97: 6049-6054, 2000. (Pubitemid 30367521)
10. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H and Imai K: Inactivation of the 14-3-3 sigma gene is associated with 5′ CpG island hypermethylation in human cancers. Cancer Res 60: 4353-4357, 2000. (Pubitemid 32103610)
11. Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T and Imai K: Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Oncogene 19: 5298-5302, 2000.
12. Henrique R, Jeronimo C, Hoque MO, Carvalho AL, Oliveira J, Teixeira MR, Lopes C and Sidransky D: Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions. DNA Cell Biol 24: 264-269, 2005. (Pubitemid 40490265)
13. Osada H, Tatematsu Y, Yatabe Y, Nakagawa T, Konishi H, Harano T, Tezel E, Takada M and Takahashi T: Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers. Oncogene 21: 2418-2424, 2002. (Pubitemid 34407301)
14. Ide M, Nakajima T, Asao T and Kuwano H: Inactivation of 14-3-3sigma by hypermethylation is a rare event in colorectal cancers and its expression may correlate with cell cycle maintenance at the invasion front. Cancer Lett 207: 241-9, 2004.
15. Martin D, Brown-Luedi M and Chiquet-Ehrismann R: Tenascin-C signaling through induction of 14-3-3 tau. J Cell Biol 160: 171-175, 2003. (Pubitemid 36254951)
16. Chiquet-Ehrismann R, Chiquet M: Tenascins: regulation and putative functions during pathological stress. J Pathol 200: 488-499, 2003. (Pubitemid 36818249)
17. Kino T, Souvatzoglou E, De Martino MU, Tsopanomihalu M, Wan Y and Chrousos GP: Protein 14-3-3sigma interacts with and favors cytoplasmic subcellular localization of the glucocorticoid receptor, acting as a negative regulator of the glucocorticoid signaling pathway. J Biol Chem 278: 25651-25656, 2003. (Pubitemid 36835319)
18. Moreira JM, Ohlsson G, Rank FE and Celis JE: Down-regulation of the tumor suppressor protein 14-3-3sigma is a sporadic event in cancer of the breast. Mol Cell Proteomics 4: 555-569, 2005. (Pubitemid 40590572)
19. Guweidhi A, Kleeff J, Giese N, Fitori JE, Ketterer K, Giese T, Buchler MW, Korc M and Friess H: Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis. Carcinogenesis 25: 1575-1585, 2004. (Pubitemid 39214299)
20. Perathoner A, Pirkebner D, Brandacher G, Spizzo G, Stadlmann S, Obrist P, Margreiter R and Amberger A: 14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Clin Cancer Res 11: 3274-3279, 2005. (Pubitemid 40627875)
21. Moreira JM, Gromov P and Celis JE: Expression of the tumor suppressor protein 14-3-3 sigma is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial-to-mesenchymal transition. Mol Cell Proteomics 3: 410-419, 2004. (Pubitemid 38713923)
22. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R and Kirchner T: Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 98: 10356-10361, 2001. (Pubitemid 32803024)
23. Beiter K, Hiendlmeyer E, Brabletz T, Hlubek F, Haynl A, Knoll C, Kirchner T and Jung A: beta-Catenin regulates the expression of tenascin-C in human colorectal tumors. Oncogene 24: 8200-8204, 2005. (Pubitemid 41759818)
24. Samuel T, Weber HO, Rauch P, Verdoodt B, Eppel JT, McShea A, Hermeking H and Funk JO: The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax. J Biol Chem 276: 45201-45206, 2001.
25. Liu Y, Liu H, Han B, Zhang JT: Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis. Cancer Res 66: 3248-3255, 2006.
26. Yang H, Wen YY, Zhao R, Lin YL, Fournier K, Yang HY, Qiu Y, Diaz J, Laronga C and Lee MH: DNA Damage-Induced Protein 14-3-3 sigma inhibits protein kinase B/Akt Activation and suppresses Akt-activated cancer. Cancer Res 66: 3096-3105, 2006.